Related Experiment Video
Updated: Jul 2, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study
Giorgio Walter Canonica1, Federica Fumagalli, Laura Guerra
1University of Genoa, Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa, Italy. canonica@unige.it
Continuous levocetirizine 5 mg daily offers better symptom control for persistent allergic rhinitis than on-demand use. This regimen also shows a trend towards improved quality of life and reduced nasal inflammation over six months.
Area of Science:
- Allergology and Immunology
- Pharmacology
- Clinical Medicine
Background:
- Allergic rhinitis significantly impacts patient quality of life (QOL), sleep, and productivity.
- Persistent allergic rhinitis is particularly troublesome and requires effective management strategies.
Purpose of the Study:
- To compare the efficacy of continuous daily levocetirizine 5 mg versus on-demand levocetirizine 5 mg in adults with persistent allergic rhinitis.
- To assess the impact of both treatment regimens on symptom scores, QOL, sleep quality, and nasal inflammation.
Main Methods:
- A 6-month, randomized, open-label pilot study involving symptomatic patients with persistent allergic rhinitis.
- Patients received either continuous daily levocetirizine 5 mg or on-demand levocetirizine 5 mg.
- Symptom scores, QOL, sleep quality, nasal cytology, drug intake, and safety were monitored.
Main Results:
- Both continuous and on-demand levocetirizine improved symptoms and QOL.
- Continuous therapy demonstrated superior symptom control from week 15 onwards, with statistical significance noted later in the study.
- Both treatments were well-tolerated, though the on-demand group reported more adverse events.
Conclusions:
- Levocetirizine 5 mg effectively manages persistent allergic rhinitis over six months.
- Continuous daily administration shows a trend towards greater efficacy in symptom control, QOL improvement, and reduced nasal inflammation compared to on-demand use.
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma III: Clinical Manifestations
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
